Clinical Trial Update: Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating Interleukin-12 for treating cryptosporidiosis in AIDS patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptosporidiosis
• HIV Infection

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Cryptosporidiosis | Phase 1, Phase 2 | Status: TERMINATED